BioNexus Gene Lab (BGLC) FCF Margin (2018 - 2026)
BioNexus Gene Lab recorded quarterly FCF Margin of 647.91% in Q1 2026, down 426.46% quarter-over-quarter from 198.46% in Q4 2025, and down 60893.0% year-over-year from N/an in Q1 2025.
BioNexus Gene Lab's FCF Margin history runs 9 years deep, the most recent figure standing at 647.91% for Q1 2026.
- In Q1 2026, FCF Margin fell 60893.0% year-over-year to 647.91%; the TTM figure through Mar 2026 stood at 22.41% (up 1098.0% YoY), while the FY2025 annual figure was 25.26%, down 86.0% from the prior year.
- FCF Margin came in at 647.91% for Q1 2026 at BioNexus Gene Lab, down from 198.46% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 198.46% in Q4 2025 to a low of 647.91% in Q1 2026.
- A 5-year average of 42.88% and a median of 6.59% in 2022 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin soared 18994 bps in 2025 and sank 60893 bps in 2026, its largest moves.
- BioNexus Gene Lab's FCF Margin stood at 16.79% in 2022, then slumped by 305 bps to 34.47% in 2023, then surged by 125 bps to 8.53% in 2024, then jumped by 2228 bps to 198.46% in 2025, then slumped by 426 bps to 647.91% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 647.91%, 198.46%, and 48.86% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn | 10.23% |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn | - |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn | 0.01% |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn | 18.06% |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn | 34.80% |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn | -0.48% |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn | -7.48% |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn | 17.33% |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn | 7.73% |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 | -647.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -647.91% |
| Dec 31, 2025 | 198.46% |
| Sep 30, 2025 | -48.86% |
| Jun 30, 2025 | -33.60% |
| Mar 31, 2025 | -38.98% |
| Dec 31, 2024 | 8.53% |
| Sep 30, 2024 | -68.52% |
| Jun 30, 2024 | -34.14% |
| Mar 31, 2024 | -2.48% |
| Dec 31, 2023 | -34.47% |
| Sep 30, 2023 | -39.40% |
| Jun 30, 2023 | -2.54% |
| Mar 31, 2023 | -4.91% |
| Dec 31, 2022 | 16.19% |
| Sep 30, 2022 | 10.55% |
| Jun 30, 2022 | -6.59% |
| Mar 31, 2022 | -2.31% |
| Dec 31, 2021 | 14.84% |
| Sep 30, 2021 | 8.82% |
| Jun 30, 2021 | -29.29% |
| Mar 31, 2021 | 3.32% |
| Dec 31, 2020 | 12.39% |
| Sep 30, 2020 | 24.42% |
| Jun 30, 2020 | -14.25% |
| Mar 31, 2020 | -31.85% |
| Dec 31, 2019 | -123.48% |
| Sep 30, 2019 | -222.91% |
| Jun 30, 2019 | -354.68% |
| Mar 31, 2019 | -120.80% |
| Dec 31, 2018 | 2,775.37% |